Cargando…
Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382737/ https://www.ncbi.nlm.nih.gov/pubmed/34426572 http://dx.doi.org/10.1038/s41392-021-00722-0 |
_version_ | 1783741598588207104 |
---|---|
author | Zhang, Zhihui Sun, Nan He, Jie |
author_facet | Zhang, Zhihui Sun, Nan He, Jie |
author_sort | Zhang, Zhihui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8382737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83827372021-09-14 Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs Zhang, Zhihui Sun, Nan He, Jie Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-08-23 /pmc/articles/PMC8382737/ /pubmed/34426572 http://dx.doi.org/10.1038/s41392-021-00722-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Highlight Zhang, Zhihui Sun, Nan He, Jie Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title | Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title_full | Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title_fullStr | Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title_full_unstemmed | Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title_short | Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs |
title_sort | adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pcrs |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382737/ https://www.ncbi.nlm.nih.gov/pubmed/34426572 http://dx.doi.org/10.1038/s41392-021-00722-0 |
work_keys_str_mv | AT zhangzhihui adjuvantimmunotherapyinresectedesophagealsquamouscellcarcinomaagospeltothenonpcrs AT sunnan adjuvantimmunotherapyinresectedesophagealsquamouscellcarcinomaagospeltothenonpcrs AT hejie adjuvantimmunotherapyinresectedesophagealsquamouscellcarcinomaagospeltothenonpcrs |